Ergomed opts for Trialbee recruitment tech for rare diseases center
Ergmomed’s new rare disease clinical trial innovation center will use patient recruitment technology developed by Trialbee.
The Sweden-based tech firm teamed up with North Carolina’s Ergomed last week, explaining the idea is to leverage the platform to enhance “patient centricity” and help sponsors avoid delays.
Trialbee CEO Matt Waltz said, said combining his firm’s technologies with Ergomed systems would “provide patients a frictionless journey into clinical research for rare disease, while reducing the enrolment on sites.”
Rare diseases are a major focus for pharmaceutical developers. On one level there is significant unmet need. According to the organization behind rare disease day more than 400 million people suffer from a rare disease.
There is also a lack of treatments for rare diseases. According to data from Global Genes, 95% of rare disease do not have an approved treatment.
Zizi Uzezi Imatorbhebhe, head of Ergomed’s center, said “Rare Disease Drug Development is one of the fastest growing areas in drug development with a 12-14% annual growth rate, accounting for about one third of the drugs in development.
“We are thrilled to partner with Trialbee,” Imatorbhebhe said, adding the collaboration “will leverage Ergomed’s experience in doing hundreds of Rare Disease studies in conjunction with innovative approaches from Trialbee to help Rare Disease Sponsors and Sites address challenges in Rare Disease Patient Recruitment.”
Recruitment challenges
And recruitment is a challenge according to Trialbee, which says 30% of all investigational products are being developed for the treatment of rare diseases.
The firm tries to address this by using a real-world data (RWD) powered recruitment engine and SaaS-based enrolment platform to identify, recruit and enroll participants.
The partnership comes just a few weeks after Ergomed acquired Adamas Consulting, a quality assurance services provider that focuses on the assessment of clinical trials and drug manufacturing processes.
Image: Stock Photo Secrets